Tim Kutzkey

CIK 1614186 · last filed 2026-05-19

Tim Kutzkey is a corporate insider who has filed 16 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for SRZNW, was dated May 19, 2026. Across all open-market trades the lifetime net is +$33.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.4K across reported positions. 96 SEC filings were submitted jointly with PONOI CAPITAL, LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.4K

Companies

2

Total Filings

16

Lifetime Open-Market Net

$33.69M

Filer Profile

Reported Address

1700 OWENS STREET
SUITE 500
SAN FRANCISCO, CA 94158

Related Filers

PONOI CAPITAL, LP — 96 joint filings, latest 2024-12-23

Ponoi Management, LLC — 96 joint filings, latest 2024-12-23

Ponoi Capital II, LP — 92 joint filings, latest 2024-12-23

Ponoi II Management, LLC — 92 joint filings, latest 2024-12-23

COLUMN GROUP II, LP — 84 joint filings, latest 2024-12-23

Column Group II GP, LP — 84 joint filings, latest 2024-12-23

COLUMN GROUP L P — 74 joint filings, latest 2024-04-08

Column Group Management LP — 62 joint filings, latest 2024-04-08

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
SRZNW	Director	900,292	$0.00	$1.4K	$11.98M	12	2026-05-19
NGM BIOPHARMACEUTICALS INC (NGM) Delisted	10%+ Owner	11,154,337	$1.54	$17.18M	$21.70M	4	2022-05-26

Recent Filings

16 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-05-19	SRZNW	Grant (A)	—	$0	EDGAR
2026-01-20	SRZNW	Buy (P)	+32,507	$641.6K	EDGAR
2026-01-15	SRZNW	Buy (P)	+17,993	$357.4K	EDGAR
2026-01-08	SRZNW	Buy (P)	+15,100	$300.3K	EDGAR
2025-12-08	SRZNW	Buy (P)	+36,150	$694.9K	EDGAR
2025-12-02	SRZNW	Buy (P)	+315,457	$3.99M	EDGAR
2025-03-28	SRZNW	Grant (A)	—	$0	EDGAR
2024-06-06	SRZNW	Grant (A)	—	$0	EDGAR
2024-04-17	SRZNW	Buy (P)	+193,548	$3.00M	EDGAR
2024-04-08	SRZNW	Buy (P)	+193,548	$3.00M	EDGAR

Showing 1–10 of 16

Page 1 of 2 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.